13LBA Improved overall survival by adding regional hyperthermia to neo-adjuvant chemotherapy in patients with localized high-risk soft tissue sarcoma (HR-STS): Long-term outcomes of the EORTC 62961/ESHO randomized phase III study. Issue 3 (September 2015) - Issels, R.D.; Lindner, L.H.; Ghadjar, P.; Reichardt, P.; Hohenberger, P.; Verweij, J.; Abdel-Rahman, S.; Daugaard, S.; Salat, C.; Vujaskovic, Z.; Wessalowski, R.; Duerr, H.R.; et al.